Hepatitis B Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults aged 18 or older
• People who have a long-term (chronic) hepatitis B virus infection, at any stage
• People who are currently taking antiviral medication for hepatitis B (called nucleoside analogues), or those who are not on any treatment
• People who also have a hepatitis D virus (HDV) infection, or those who do not
• People who are already enrolled in a separate related study called the CirB-RNA study (NCT03825458)
• People who have been fully informed about the study and have signed a consent form

Who may not be able to join:

• Women who are pregnant, in labour, or currently breastfeeding
• People whose liver disease has become severely advanced (decompensated cirrhosis)
• People who have liver cancer, or where liver cancer is suspected
• People who have had a liver transplant, even if the transplant was due to hepatitis B
• People who also have an active hepatitis C infection or an HIV infection
• People who are currently taking part in another clinical trial that involves a treatment or intervention
• People who are under psychiatric care
• People who are living in a health or social care facility for reasons unrelated to research
• Adults who are under a legal protection order (such as guardianship or curatorship)
• People who are not covered by a social security or equivalent health insurance scheme
• People who have skin problems or infections on their abdomen (stomach area)
• People who have an allergy or sensitivity to lidocaine (a local anaesthetic used in the study)

Important: Always verify eligibility with the trial site directly before applying.